Myocardioprotective Effects of Felodipine in an Antihypertensive Dosage: An Experimental Study in Pigs

Kloner R, Przyklenl K. Experimental infarct size reduction with calcium channel blockers. J Am Coll Cardiol 1991;18:876-878. Haga Y, Hatori N, Nordlander M, SjÖquist P-O, Rydén L. Coronary venous retroperfusion of felodipine reducing infarct size without affecting regional myocardial blood flow. Eur Heart J 1993;14:1386-1393. Hohlfeld T, Braun M, Strobach H, SchrÖr K. Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonist. J Cardiovasc Pharmacol 1994;23:922-931. Walker L, Mackenzie A, Adgey J. Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction. Br Heart J 1988; 39:403-410. The Israeli SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial in patients with acute myocardial infarction. Eur Heart J 1988;9:354-364. Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-392. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990;66: 779-785. Held PH, Yusuf S. Effects of yblockers and calcium channel blockers in acute myocardial infarction. Eur Heart J 1993; 14(Suppl. F):18-25. O'Mailia K, Kelly J, O'Brien E. Clinical benefits of structural and functional changes with calcium antagonists. Am Heart J 1991;122:370-374. Packer M. Calcium channel blockers in chronic heart failure: The risk of “physiologically rational” therapy. Circulation 1990;82:2254-2257. Heusch G. Ischemia-selectivity: A new concept of cardioprotection by calcium antagonists. Basic Res Cardiol 1994;89: 2-5. Ljung B. Vascular selectivity of felodipine: Experimental pharmacology. J Cardiovasc Pharmacol 1990;15(Suppl. 4): S11-S16. Thoren P, SjÖlander M, Nordlander M. Hemodynamic effects of calcium antagonists with high and low vascular selectivity. J Cardiovasc Pharmacol 1990;15(Suppl. 4): S21-S24. Haga Y, Uriuda Y, BjÖrkman J-A, et al. Ischemic and nonischemic tissue concentration of felodipine after coronary venous retroinfusion during myocardial ischemia and reperfusion: An experimental study in pig. J Cardiovasc Pharmacol 1994;24:298-302. Ahnoff M. Determination of felodipine in plasma by gas chromatography with election capture detection. J Pharm Biomed Anal 1984; 52: 431-434. Fishbein MC, Meerbaum S, Rit J. Early phase acute myocardial infarct size quantification. Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600. Inou T, Lamberth WC Jr., Koyanagi S, Harrison DG, Eastham CL, Marcus ML. Relative importance of hypertension after coronary occlusion in chronic hypertensive dogs with LVH. Am J Physiol 1987;253:H1148-H1158. Dellsperger KC, Clothier JL, Koyanagi S, Inou T, Marcus ML. Effects of coronary artery occlusion in animals with hypertension and left ventricular hypertrophy. J Cardiovasc Pharmacol 1991;17(Suppl. 2): 40-45. Hammerman H, Kloner RA, Alker KJ, Schoen FJ, Braunwald E. Effects of transient increased afterload during experimentally induced acute myocardial infarction in dogs. Am J Cardiol 1985;55:566-570. Dellsperger KC, Martins JB, Clothier JL, Marcus ML. Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade. Circulation 1990;82:941-950. Dunselman PHJM, Edgar B. Felodipine clinical pharmacokinetics. Clin Pharmacokinet 1991;21:418-430. Franciosa JA, Limas CJ, Guiha NH, Roderiguera ER, Cohn JN. Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet 1972;1: 650-654. Johnsson G, Murry G, Tweddel A, Hutton I. Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects. Eur J Clin Pharmacol 1983;24:49-53. Timmis AD, Campbell S, Monaghan MJ, Walker L, Jewitt DE. Acute haemodynamic and metabolic effects of felodipine in congestive heart failure. Br Heart J 1984;51:445-451. SjÖquist P-O, Duker G, Almgren O. Distribution of the collateral blood flow at the lateral border of the ischemic myocardium after acute coronary occlusion in the pig and the dog. Basic Res Cardiol 1984;79:164-175. Hearse DJ, Muller CA, Fukanami M, Kudoh Y, Opie LH, Yellon DM. Regional myocardial ischemia: Characterization of temporal, transmural and lateral flow interfaces in the porcine heart. Can J Cardiol 1986;2:48-61. Opie LH. Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity. Cardiovasc Drugs Ther 1992;6:19-24. Bean BP. Nitrendipine block of cardiac calcium channels: High-affinity binding to the inactivated state. Proc Natl Acad Sci 1984;81:6388-6392. Godfrain T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 1986;38:321-416. Sanguinetti MC, Kass RS. Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res 1984;55:336-348. Nayer WG, Ferrari R, Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfusion myocardium. Am J Cardiol 1980;46:242-248. De Jong JW, Harmsen E, De Tombe PP. Diltiazem administered before or during myocardial ischemia decreases adenine nucleotide catabolism. J Mol Cell Cardiol 1984;16: 363-370. Taylor AL, Golino P, Eckels R, Pastor P, Buja LM, Willerson JT. Differential enhancement of postischemic segmental systolic thickening by diltiazem. J Am Coll Cardiol 1990;15: 737-747. Janero DR, Burghardt B. Antioxidant effects of dihydropyridine calcium antagonists. Biochem Pharmacol 1989; 38:4344-438. Chintala MS, Jacinto S, Jandhyala BS. Studies on the deleterious effects of free radicals on myocardial contractility and hemodynamics in dogs: Protection by felodipine, a dihydropyridine calcium antagonist. Drug Dev Res 1992;27: 287-295. Sullivan AT, Baker DJ, Drew GM. Effect of calcium channel blocking agents on infarct size after ischemic-reperfusion in anaesthetised swine: Relationship between cardioprotection and cardiodepression. J Cardiovasc Pharmacol 1991;17: 707-717. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effect of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by coronary sodium nitroprusside infusion. Circulation 1994;89:2070-2078. Masini E, Bianchi S, Mugnai L, Gambassi F, Lupini M, Pistelli A, Mannaioni PF. The effect of nitric oxide generators on ischemic reperfusion injury and histamine release in isolated perfusion guinea-pig heart. Agents Actions 1991; 33:53-56.